Background
In order to induce significant tumor regression T cells must effectively recognize and kill target cells. Secretion of IFN-γ is considered a key effector function of activated CD8 + T cells via induction of apoptosis. Thus programming T cells to secrete high levels of IFN-γ after adoptive transfer could represent a therapeutically effective anti-cancer intervention.
Methods
We previously demonstrated that naïve CD8 + T cells exposed to IL-12 during antigenic priming (Pmel Ag+12 ) provided superior anti-tumor activity after transfer when compared to cells activated in the presence of antigen alone (Pmel Ag ). In this setting, tumor regression was associated with sustained levels of intra-tumoral IFN-γ. Expression analysis using total tumor RNA showed elevated expression of IFN-γ responsive genes such as IP-10, MCP-1, MIG, and MIP-1α. Even without IL-12 stimulation during ex vivo antigenic priming, Pmel cells were able to initially reach the tumor and secrete high levels of IFN-γ. However, by day 7 after adoptive transfer tumors in mice that received Pmel Ag were significantly larger than those in mice injected with Pmel Ag+12 . Failure to maintain intra-tumoral levels of IFN-γ was associated with a decrease in the frequency of tumor infiltrating Pmel Ag . We hypothesized that high levels of IFN-γ had a detrimental effect on Pmel Ag , via induction of apoptosis. IFN-γ is a multifunctional cytokine that induces a variety of contrasting cell responses such as proliferation or cell death. The cellular response to an IFN-γ stimulus depends on the specific receptor being activated, with IFN-γR1 inducing proliferation and IFN-γR2 inducing apoptosis.
Results
We tested the hypothesis that the ability of T cells to survive in vivo after adoptive transfer was dependent on their susceptibility to IFN-γ-induced apoptosis. Real time PCR revealed that the expression levels of IFN-γR1 and IFN-γR2 immediately following antigen or antigen+ IL-12 priming were similar, though by 4d post adoptive transfer the tumor-infiltrating Pmel cells stimulated with antigen alone had 10 fold higher levels of IFN-γR2 than tumor associated Pmel Ag+IL-12 .
Conclusions
These results suggest that the enhanced anti-tumor activity of Pmel Ag+IL-12 might be due to their decreased sensitivity to IFN-γ-induced apoptosis. Thus inhibiting IFN-γ-induced activation induced cell death (AICD) by down-regulating IFN-γR2 expression on T cells may represent a novel mechanism by which IL-12 enhances anti-tumor activity.
